Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension

Overview

This study aim to look into the prevalence of Vitamin D deficiency among Malaysian pregnant women and its associated risk factors. Subsequently, vitamin D deficient women with and without gestational hypertension will be investigated for their genetic variation to look for the association of VDR genetic variation and hypertensive disorders in pregnancy.

Full Title of Study: “Association of Vitamin D Deficiency With Selected Vitamin D Receptor (VDR) Gene Polymorphism in Gestational Hypertension Among Malaysian Women: A Prospective Genetic Biomarker for Early Intervention Strategy”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 28, 2024

Detailed Description

Hypertensive disorders of pregnancy account for approximately 14% of maternal mortality globally and is the fourth leading cause of maternal mortality in Malaysia. Despite this, the mechanisms and pathogenesis are still unknown. Vitamin D deficiency (hypovitaminosis vitamin D) has been shown to be one of the causes of gestational hypertension(GH). Several populations have observed the association of single nucleotide polymorphisms (SNPs) of vitamin D receptor (VDR) to vitamin D deficiency among pregnancy complications, including GH. Alarming cases of hypovitaminosis D in sunny areas including Malaysia, highly imply the need to understand the genetic factor. Hence, genotyping VDR variants among pregnant women is essential for early vitamin D supplementation strategy. To investigators knowledge, there has been no published study conducted among Malaysian population on the association of VDR genetic variation and GH. Therefore, this study aim to investigate the prevalence of vitamin D deficiency and its association of VDR SNPs to the development of GH among Malaysian pregnant mothers, with the main focus on Malays, representing the largest ethnic in Malaysia. The prevalence will be determined through a cross-sectional study involving 363 pregnant women recruited in Hospital Pengajar UPM (HPUPM) and Hospital Serdang, Selangor. Relevant socio-demographic, clinical and anthropometric data will be collected using structured interviewer-administered questionnaire. Blood specimens for the analysis of vitamin D will be done. The association will be determined in a case-control study involving 180 pregnant women who fulfilled the criteria, recruited from phase 1 study. Their blood will be further analysed for the variants of the VDR gene [(BsmI(rs1544410), FokI(rs2228570), TaqI(rs731236)] to look for the association. This study expected to provide more evidence for early personalised intervention of vitamin D supplementation due to anticipated individual genetic variability. This antenatal care programme will reduce the government expenditures, reduce maternal and fetal morbidity and mortality while strengthening Malaysia's healthcare system.

Interventions

  • Diagnostic Test: Blood taking
    • Blood test for vitamin D level and DNA extraction for VDR gene polymorphism

Arms, Groups and Cohorts

  • 1- normotensive women
    • Women with vitamin D deficiency and normotensive during pregnancy
  • 2- women with hypertensive disorder in pregnancy
    • Women with Vitamin D deficiency and hypertensive disorder in pregnancy

Clinical Trial Outcome Measures

Primary Measures

  • Prevalence of vitamin D deficiency
    • Time Frame: 1 year
    • To determine the prevalence of Vitamin D deficiency among Malaysian pregnant mothers
  • Risk factors of vitamin D deficiency
    • Time Frame: 1 year
    • To determine the associated risk factors of vitamin D deficiency among Malaysian pregnant mothers-weight, height and BMI will be measured in kg/m2.
  • Risk factors of vitamin D deficiency
    • Time Frame: 1 year
    • To determine the associated risk factors of vitamin D deficiency among Malaysian pregnant mothers-duration of sun exposure in a week, measured in hours
  • Risk factors of vitamin D deficiency
    • Time Frame: 1 year
    • To determine the associated risk factors of vitamin D deficiency among Malaysian pregnant mothers-intake of food rich in vitamin D, measured in serving number per week
  • VDR allele and genotype
    • Time Frame: 1 year
    • To understand and associate distributions of VDR allele and genotype with vitamin D deficiency among Malay pregnant mothers
  • VDR-combined genotypes and gestational hypertension
    • Time Frame: 6 months
    • To associate VDR-combined genotypes with the risk to develop gestational hypertension in vitamin D deficient Malay pregnant women

Participating in This Clinical Trial

Inclusion Criteria

1. Malay pregnant women with gestational age between 20 weeks till 42 weeks. (The gestational age will be determined from the first day of the last menstrual cycle or measurement of fetal crown rump length) 2. Malay pregnant women with viable pregnancy with or without pregnancy induced hypertension or its complications (pre-eclampsia, eclampsia, HELLP syndrome etc). 3. Literate in either English or Malay languages. 4. Agreement to follow-up till delivery and provision of written informed consent. Exclusion Criteria:

1. Non-viable pregnancy at the time of recruitment. 2. Women already on vitamin D supplements or any other drugs that can interfere with vitamin D absorption or metabolism at the time of recruitment. 3. Women with chronic hypertension diagnosed prior to pregnancy. 4. Pregnant women with any other chronic disease that is known to affect vitamin D such as, autoimmune disease and any malignancy

Gender Eligibility: Female

Minimum Age: 19 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Universiti Putra Malaysia
  • Collaborator
    • Ministry of Higher Education, Malaysia
  • Provider of Information About this Clinical Study
    • Principal Investigator: Nurul Iftida Binti Basri, Dr – Universiti Putra Malaysia
  • Overall Official(s)
    • Nurul I Basri, MbChb, Principal Investigator, Universiti Putra Malaysia
  • Overall Contact(s)
    • Nurul I Basri, 0397699339, nurul.iftida@upm.edu.my

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.